Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
2 studies found for:    15014352 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Terminated Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Biological: Opioid Growth Factor (OGF)
2 Completed Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
Condition: Pancreatic Cancer
Interventions: Biological: opioid growth factor;   Biological: metenkephalin, OGF-opioid growth factor
To Top

† Indicates status has not been verified in more than two years